F2RL1 and colorectal carcinoma: Given the established role of ERK signalling in promoting proliferation, survival, and inflammatory responses downstream of PAR-2 in CRC, these results suggest that the previously observed suppression of PAR-2 expression by statins translates into functional attenuation of a key effector pathway, thereby reinforcing their potential therapeutic utility in inflammatory and neoplastic conditions of the colon.